Chris Owens Head Shot 2022
R3 Vascular Announces $87 Million in Series B Financing and Appoints Christopher M. Owens as new President and CEO
09 mai 2024 12h00 HE | R3 Vascular
R3 Vascular, Inc. announced the closing of its $87 million Series B financing round and the appointment of a new President and Chief Executive Officer
sphericalinsightsoptionblue.png
Global Airway Stent Market Size To Worth USD 14.5 Billion By 2030 | CAGR of 7.7%
28 mars 2023 13h30 HE | SPHERICAL INSIGHTS LLP
New York, United States , March 28, 2023 (GLOBE NEWSWIRE) -- The Global Airway Stent Market Size to grow from USD 8.8 Billion in 2021 to USD 14.5 Billion by 2030, at a Compound Annual Growth Rate...
Dr. Scott Kelley.PNG
Dr. Scott & Jill Kelley Introduce Life-Saving Medical Technology to Curb Postoperative Complications and Deaths
20 déc. 2022 17h00 HE | Dr. Scott Kelley
TAMPA, FLORIDA, Dec. 20, 2022 (GLOBE NEWSWIRE) -- Dr. Scott & Jill Kelley Introduce Life-Saving Medical Technology to Curb Postoperative Complications and Deaths Entrepreneurs Dr. Scott and...
AMR Logo.png
Vascular Graft Market Size is Expected to Reach $8.13 Billion by 2030: Allied Market Research
13 juin 2022 07h25 HE | Allied Market Research
Portland, OR, June 13, 2022 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global Vascular Graft Market generated $4.99 billion in 2020, and is projected to...
insightSLICE.png
Gel Stent Market Global Sales Are Expected To Reach US$ 4.90 Billion by 2030, as stated by insightSLICE
01 mars 2021 09h51 HE | insightSLICE
PUNE, India, March 01, 2021 (GLOBE NEWSWIRE) -- The Global Gel Stent Market Share, Trends, Analysis and Forecasts, 2020-2030 provides insights on key developments, business strategies, research...
AngioSoma.jpg
AngioSoma Focusing on Development of Coating for Metal Stents
27 mai 2020 10h42 HE | AngioSoma, Inc.
Houston, TX, May 27, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- AngioSoma, Inc. (OTC: SOAN) (“AngioSoma” or the “Company”) is pleased to announce that the Company is focusing on development and...
Amaranth Medical
Amaranth Presented MAGNITUDE (98 micron) Nine-Month Follow-up Clinical Results and Introduced DEFIANCE (85 micron) BRS Development Plan at TCT
24 sept. 2018 07h59 HE | Amaranth Medical, Inc.
MOUNTAIN VIEW, CA , Sept. 24, 2018 (GLOBE NEWSWIRE) -- Amaranth Medical, a medical device company developing next-generation bioresorbable scaffolds, provided an update on the company’s...
InspireMD Logo.png
InspireMD’s CGuard EPS Featured at the SBHCI Congress in Brazil
20 juin 2018 07h20 HE | InspireMD, Inc.
Tel Aviv, Israel, June 20, 2018 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE AMER:NSPR), a leader in embolic prevention systems (EPS) / thrombus management technologies and neurovascular devices, today...
InspireMD Logo.png
InspireMD’s CGuard EPS Prominently Featured at the 10th International Congress of the Polish Society for Vascular Surgery
18 juin 2018 09h42 HE | InspireMD, Inc.
Study results presented from 46 patients treated over two years with zero complicationsPresident of the Polish Society for Vascular Surgery presented clinical cases illustrating the advantages of...
healthcare
Remarkable New Healthcare Innovations Made Possible by Plastics
30 mai 2016 14h54 HE | Canadian Plastics Industry Association
TORONTO, May 30, 2016 (GLOBE NEWSWIRE) -- Healthcare innovations continue to amaze, particularly those enabled by plastics. Advances in medical technology touch all of us, from preemie babies to...